Specific somatostatin receptor II expression in arterial plaque: 68Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice

Atherosclerosis

Volumn 230, Issue 1, 2013, Pages 33-39

  Li, Xiang ^a   Bauer, Wolfgang ^a   Kreissl, Michael C ^a   Weirather, Johannes ^a   Bauer, Elisabeth ^a   Israel, Ina ^a   Richter, Dominik ^a   Riehl, Gabriele ^a   Buck, Andreas ^a   Samnick, Samuel ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

68Ga DOTATATE; Atherosclerosis; Autoradiography; Inflammation; Somatostatin receptor subtype2

Indexed keywords

GALLIUM 68; LIPOPOLYSACCHARIDE; SOMATOSTATIN RECEPTOR 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTORADIOGRAPHY; CHOLESTEROL DIET; FLOW CYTOMETRY; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

(68)GA-DOTATATE; ATHEROSCLEROSIS; AUTORADIOGRAPHY; INFLAMMATION; SOMATOSTATIN RECEPTOR SUBTYPE2;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GALLIUM RADIOISOTOPES; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MICE; MICE, TRANSGENIC; MONOCYTES; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, SOMATOSTATIN;

EID: 84881641704     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.06.018     Document Type: Article

References (33)

1. Deitch E.A. Multiple organ failure. Pathophysiology and potential future therapy. Annals of Surgery 1992, 216:117-134.
2. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
3. Hansson G.K. Immune mechanisms in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2001, 21:1876-1890.
4. Ross R. Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999, 340:115-126.
5. Cordeiro M.A., Lima J.A. Atherosclerotic plaque characterization by multidetector row computed tomography angiography. Journal of the American College of Cardiology 2006, 47:C40-C47.
6. Fayad Z.A., Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circulation Research 2001, 89:305-316.
7. Tearney G.J., Jang I.K., Bouma B.E. Optical coherence tomography for imaging the vulnerable plaque. Journal of Biomedical Optics 2006, 11:021002.
8. Nahrendorf M., Keliher E., Panizzi P., Zhang H., Hembrador S., Figueiredo J.L., et al. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovascular Imaging 2009, 2:1213-1222.
9. Ogawa M., Ishino S., Mukai T., Asano D., Teramoto N., Watabe H., et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. Journal of Nuclear Medicine: Official Publication. Society of Nuclear Medicine 2004, 45:1245-1250.
10. Tawakol A., Migrino R.Q., Bashian G.G., Bedri S., Vermylen D., Cury R.C., et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. Journal of the American College of Cardiology 2006, 48:1818-1824.
11. Rudd J.H., Myers K.S., Bansilal S., Machac J., Pinto C.A., Tong C., et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. Journal of Nuclear Medicine: Official Publication. Society of Nuclear Medicine 2008, 49:871-878.
12. Zhang Z., Machac J., Helft G., Worthley S.G., Tang C., Zaman A.G., et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nuclear Medicine 2006, 6:3.
13. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arteriosclerosis, Thrombosis, and Vascular Biology 1998, 18:842-851.
14. Peter K., Nawroth P., Conradt C., Nordt T., Weiss T., Boehme M., et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:505-512.
15. Tsourkas A., Shinde-Patil V.R., Kelly K.A., Patel P., Wolley A., Allport J.R., et al. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjugate Chemistry 2005, 16:576-581.
16. McAteer M.A., Sibson N.R., von Zur Muhlen C., Schneider J.E., Lowe A.S., Warrick N., et al. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nature Medicine 2007, 13:1253-1258.
17. Burtea C., Laurent S., Murariu O., Rattat D., Toubeau G., Verbruggen A., et al. Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. Cardiovascular Research 2008, 78:148-157.
18. Boutry S., Laurent S., Elst L.V., Muller R.N. Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Media & Molecular Imaging 2006, 1:15-22.
19. Schafers M., Riemann B., Kopka K., Breyholz H.J., Wagner S., Schäfers K.P., et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004, 109:2554-2559.
20. Isobe S., Tsimikas S., Zhou J., Fujimoto S., Sarai M., Branks M.J., et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. Journal of Nuclear Medicine: Official Publication. Society of Nuclear Medicine 2006, 47:1497-1505.
21. Laitinen I., Saraste A., Weidl E., Poethko T., Weber A.W., Nekolla S.G., et al. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circulation Cardiovascular Imaging 2009, 2:331-338.
22. Rudd J.H., Narula J., Strauss H.W., Virmani R., Machac J., Klimas M., et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?. Journal of the American College of Cardiology 2010, 55:2527-2535.
23. Rudd J.H.F. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002, 105:2708-2711.
24. Wasselius J.A., Larsson S.A., Jacobsson H. FDG-accumulating atherosclerotic plaques identified with 18F-FDG-PET/CT in 141 patients. Molecular Imaging and Biology: MIB: The Official Publication of the Academy of Molecular Imaging 2009, 11:455-459.
25. Wykrzykowska J., Lehman S., Williams G., Parker J.A., Palmer M.R., Varkey S., et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. Journal of Nuclear Medicine: Official Publication. Society of Nuclear Medicine 2009, 50:563-568.
26. Armani C., Catalani E., Balbarini A., Bagnoli P., Cervia D. Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages. Journal of Leukocyte Biology 2007, 81:845-855.
27. Dalm V.A., van Hagen P.M., van Koetsveld P.M., Achilefu S., Houtsmuller A.B., Pols D.H., et al. Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. American Journal of Physiology Endocrinology and Metabolism 2003, 285:E344-E353.
28. Perez J., Viollet C., Doublier S., Videau C., Epelbaum J., Baud L. Somatostatin binds to murine macrophages through two distinct subsets of receptors. Journal of Neuroimmunology 2003, 138:38-44.
29. Rominger A., Saam T., Vogl E., Ubleis C., la Fougère C., Förster S., et al. In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. Journal of Nuclear Medicine: Official Publication. Society of Nuclear Medicine 2010, 51:193-197.
30. Li X., Samnick S., Lapa C., Israel I., Buck A.K., Kreissl M.C., et al. 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. EJNMMI Research 2012, 2:52.
31. Rudd J.H., Fayad Z.A. Imaging atherosclerotic plaque inflammation. Nature Clinical Practice Cardiovascular Medicine 2008, 5(Suppl. 2):S11-S17.
32. Bruley-Rosset M., Florentin I., Mathe G. In vivo and in vitro macrophage activation by systemic adjuvants. Agents and Actions 1976, 6:251-255.
33. Yan S., Li M., Chai H., Yang H., Lin P.H., Yao Q., et al. TNF-alpha decreases expression of somatostatin, somatostatin receptors, and cortistatin in human coronary endothelial cells. The Journal of Surgical Research 2005, 123:294-301.